Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Aug 12, 2010

Premium

Dicerna Pharmaceuticals has appointed Brian Halak to its board of directors.

Halak is a partner at investment firm Domain Associates. He joined Dicerna's board in conjunction with a Domain investment in the RNAi drug shop, and holds a PhD from Thomas Jefferson University.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.